Drugs / Pro-Thrombin Concentrate Complex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03218722 | Dec 2017 → Aug 2021 | — | University Hospital, Grenoble | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pro-Thrombin Concentrate Complex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03218722 ↗ |
| Route | Intravenous | “Intravenous administration of 1 mL/kg of 4F-PCC (25 IU of factor IX/kg)” PMID 36942533 ↗ Apr 2023 |